STADA Arzneimittel AG
23.12.2015 13:14
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Notification of Major Holdings
1. Details of issuer
STADA Arzneimittel AG
StadastraÃe 2-18
61118 Bad Vilbel
Germany
2. Reason for notification
Acquisition/disposal of shares with voting rights
X Acquisition/disposal of instruments
Change of breakdown of voting rights
X Other reason: Delta variation on listed warrants and OTC options
3. Details of person subject to the notification obligation
Name: City and country of registered office:
Societe Generale S.A. Paris
France
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
5. Date on which threshold was crossed or reached
18.12.2015
6. Total positions
% of voting % of voting rights total of total number
rights attached through instruments both in % of voting
to shares (total (total of 7.b.1 + (7.a. + rights of
of 7.a.) 7.b.2) 7.b.) issuer
Result- 0,00 % 3,70 % 3,70 % 62342440
ing
situat-
ion
Previo- 0,00 % 5,19 % 5,19 % /
us
notifi-
cation
7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)
ISIN absolute in %
direct indirect direct indirect
(Sec. 21 WpHG) (Sec. 22 WpHG) (Sec. 21 WpHG) (Sec. 22 WpHG)
% %
Total %
b.1. Instruments according to Sec. 25 Abs. 1 Nr. 1 WpHG
Type of Expiration or Exercise or Voting Voting
instrument maturity date conversion rights rights in
period absolute %
Certificat- 16.11.2020 until 16.11.2020 1552 0,002 %
es
Total 1552 0,002 %
b.2. Instruments according to Sec. 25 Abs. 1 Nr. 2 WpHG
Type of Expiration Exercise or Cash or Voting Voting
instrumen- or maturity conversion physical rights rights
t date period settlement absolute in %
Euro 20.11.2018 until Cash 15691 0,03 %
Medium 20.11.2018
Term Note
OTC 16.12.2016 until Cash 87462 0,14 %
call-opti- 16.12.2016
on
OTC 15.12.2017 until Cash 55348 0,09 %
call-opti- 15.12.2017
on
OTC 21.12.2018 until Cash 1897 0,00 %
call-opti- 21.12.2018
on
OTC 03.01.2025 until Cash 600000 0,96 %
call-opti- 03.01.2025
on
Listed 16.12.2016 until Cash 87130 0,14 %
call 16.12.2016
warrant
Listed 15.12.2017 until Cash 54208 0,09 %
call 15.12.2017
warrant
Listed 21.12.2018 until Cash 1897 0,00 %
call 21.12.2018
warrant
Listed 03.01.2025 until Cash 599406 0,96 %
call 03.01.2025
warrant
Listed 18.03.2016 18.03.2016 Cash 805000 1,29 %
call
warrant
Total 2308039 3,70 %
8. Information in relation to the person subject to the notification
obligation
Person subject to the notification obligation is not controlled and
does itself not control any other undertaking(s) holding directly
or indirectly an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate
controlling natural person or legal entity:
Name % of voting % of voting rights Total of both
rights (if at through instruments (if (if at least
least held 3% or at least held 5% or held 5% or
more) more) more)
Societe % % %
Generale
S.A.
Societe % % %
Generale
Effekten
GmbH
9. In case of proxy voting according to § 22 Abs. 3 WpHG
Date of general meeting:
Holding position after general meeting: % (equals voting rights)
23.12.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: STADA Arzneimittel AG
StadastraÃe 2-18
61118 Bad Vilbel
Germany
Internet: www.stada.de
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
DGAP-PVR: STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
| Source: EQS Group AG